[1] Lam D W, LeRoith D. The worldwide diabetes epidemic[J]. Curr Opin Endocrinol Diabetes Obes, 2012, 19(2):93-96. [2] Phielix E, Mensink M. Type 2 diabetes mellitus and skeletal muscle metabolic function[J]. Physiol & Behav, 2008, 94(2):252-258. [3] Mehta P K, Griendling K K. Angiotensin Ⅱ cell signaling:physiological and pathological effects in the cardiovascular system[J]. Am J Physiol Cell Physiol, 2007, 292(1):C82-97. [4] Sukumaran V, Watanabe K, Veeraveedu P T, et al. Olmesartan, an AT1 antagonist, attenuates oxidative stress, endoplasmic reticulum stress and cardiac inflammatory mediators in rats with heart failure induced by experimental autoimmune myocarditis[J]. Int J Biol Sci, 2011, 7(2):154-167. [5] Wu T, Dong Z, Geng J, et al. Valsartan protects against ER stress-induced myocardial apoptosis via CHOP/Puma signaling pathway in streptozotocin-induced diabetic rats[J]. Eur J Pharm Sci, 2011, 42(5):496-502. [6] Zou X J, Yang L, Yao S L. Endoplasmic reticulum stress and C/EBP homologous protein-induced Bax translocation are involved in angiotensin Ⅱ-induced apoptosis in cultured neonatal rat cardiomyocytes[J]. Exp Biol Med, 2012, 237(11):1341-1349. [7] Rabelo L A, Alenina N, Bader M. ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease[J]. Hypertens Res, 2011, 34(2):154-160. [8] Santos R A. Angiotensin-(1-7)[J]. Hypertension, 2014, 63(6):1138-1147. [9] Murugan D, Lau Y S, Lau C W, et al. Angiotensin 1-7 protects against angiotensin Ⅱ-induced endoplasmic reticulum stress and endothelial dysfunction via mas receptor[J]. PLoS One, 2015, 10(12):e0145413. [10] Uhal B D, Nguyen H, Dang M, et al. Abrogation of ER stress-induced apoptosis of alveolar epithelial cells by angiotensin 1-7[J]. Am J Physiol Lung Cell Mol Physiol, 2013, 305(1):L33. [11] O'Bfien J T, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment[J]. Lancet Neurol, 2003, 2(2):89-98. [12] Koh H J, Toyoda T, Didesch M M, et al. Tribbles 3 mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle[J]. Nat Commun, 2013, 4:1871. [13] Hwang S L,Jeong Y T,Li X,et al. Inhibitory cross-talk between the AMPK and ERK pathways mediates endoplasmic reticulum stress-induced insulin resistance in skeletal muscle[J]. Br J Pharmacol,2013,169(1):69-81. [14] Mori K. Tripartite management of unfolded proteins in the endoplasmic reticulum[J]. Cell, 2000, 101(5):451-454. [15] Rutkowski D T, Wu J, Back S H, et al. UPR pathways combine to prevent hepatic steatosis caused by ER stress-mediated suppression of transcriptional master regulators[J]. Dev Cell, 2008, 15(6):829-840. [16] Deldicque L, Hespel P, Francaux M. Endoplasmic reticulum stress in skeletal muscle:origin and metabolic consequences[J]. Exerc Sport Sci Rev, 2012, 40(1):43-49. [17] Deldicque L, Cani P D, Philp A, et al. The unfolded protein response is activated in skeletal muscle by high-fat feeding:potential role in the downregulation of protein synthesis[J]. Am J Physiol Endocrinol Metab, 2010, 299(5):E695-705. [18] Deldicque L, Bertrand L, Patton A, et al. ER stress induces anabolic resistance in muscle cells through PKB-induced blockade of mTORC1[J]. PLoS One, 2011, 6(6):e20993. [19] Nakagawa T, Zhu H, Morishima N,et al. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta[J]. Nature, 2000, 403(6765):98-103. [20] Sabio G, Davis R J. cJun NH2-terminal kinase 1(JNK1):roles in metabolic regulation of insulin resistance[J]. Trends Biochem Sci, 2010, 35(9):490-496. [21] Senn J J. Toll-like receptor-2 is essential for the development of palmitate-induced insulin resistance in myotubes[J]. J Biol Chem, 2006, 281(37):26865-26875. [22] Vijayvargia R, Mann K, Weiss H R, et al. JNK deficiency enhances fatty acid utilization and diverts glucose from oxidation to glycogen storage in cultured myotubes[J]. Obesity(Silver Spring), 2010, 18(9):1701-1709. [23] Santos F R, Diamond-Stanic M K, Prasannarong M, et al. Contribution of the serine kinase c-Jun N-terminal kinase (JNK) to oxidant-induced insulin resistance in isolated rat skeletal muscle[J]. Arch Physiol Biochem, 2012, 118(5):231-236. [24] Sabio G, Kennedy N J, Cavanagh-Kyros J, et al. Role of muscle c-Jun NH2-terminal kinase 1 in obesity-induced insulin resistance[J]. Mol Cell Biol, 2010, 30(1):106-115. [25] Bonen A, Holloway G P, Tandon N N, et al.Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats[J]. Am J Physiol Regul Integr Comp Physiol, 2009, 297(4):R1202-1212. [26] Wang H, Kouri G, Wollheim C B. ER stress and SREBP-1 activation are implicated in beta-cell glucolipotoxicity[J]. J Cell Sci, 2005, 118(Pt 17):3905. [27] Corpeleijn E, Saris W H, Blaak E E. Metabolic flexibility in the development of insulin resistance and type 2 diabetes:effects of lifestyle[J]. Obes Rev, 2009, 10(2):178-193. [28] Osborn O, Olefsky J M. The cellular and signaling networks linking the immune system and metabolism in disease[J]. Nat Med, 2012, 18(3):363-374. [29] Hotamisligil G S. Inflammation and metabolic disorders[J]. Nature, 2007, 444(7121):860-867. [30] Wu H, Ghosh S, Perrard X D, et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity[J]. Circulation, 2007, 115(8):1029-1038. [31] Guilherme A, Virbasius J V, Puri V, et al. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes[J]. Nat Rev Mol Cell Biol, 2008, 9(5):367-377. [32] Olefsky J M, Glass C K. Macrophages, inflammation, and insulin resistance[J]. Annu Rev Physiol, 2010, 72(72):219-246. [33] Samuel V T, Shulman G I. Mechanisms for insulin resistance:common threads and missing links[J]. Cell, 2012, 148(5):852-871. [34] Henriksen E J, Prasannarong M. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle[J]. Mol Cell Endocrinol, 2013, 378(1-2):15-22. [35] 赵永才,任路平,宋光耀,等.高果糖饮食对大鼠胰岛功能和胰岛葡萄糖调节蛋白78的影响[J].解放军医药杂志,2016,28(3):9-12. [36] Wei Y, Sowers J R, Clark S E, et al. Angiotensin Ⅱ-induced skeletal muscle insulin resistance mediated by NF-kappaB activation via NADPH oxidase[J]. Am J Physiol Endocrinol & Metab, 2008, 294(2):E345-351. [37] Boyce M, Yuan J. Cellular response to endoplasmic reticulum stress:a matter of life or death[J]. Cell Death Differ,2006,13(3):363-373. [38] Hwang S L, Chang H W, Lee I K, et al. Ascofuranone prevents ER stress-induced insulin resistance via activation of AMP-activated protein kinase in L6 myotube cells[J]. Biochem Biophys Res Commun, 2010,396(4):967-972. [39] Raciti G A, Iadicicco C, Ulianich L, et al.Glucosamine-induced endoplasmic reticulum stress affects GLUT4 expression via activating transcription factor 6 in rat and human skeletal muscle cells[J]. Diabetologia,2010,53(5):955-965. [40] Peng G, Li L, Liu Y, et al.Oleate blocks palmitate-induced abnormal lipid distribution,endoplasmic reticulum expansion and stress, and insulin resistancein skeletal muscle[J]. Endocrinology,2011,152(6):2206-2218. [41] Ijuin T, Hosooka T, Takenawa T, et al. Phosphatidylinositol 3,4,5-Trisphosphate phosphatase SKIP links endoplasmic reticulum stress in skeletal muscle to insulin resistance[J]. Mol Cell Biol, 2015,36(1):108-118. [42] 曹荟哲, 徐倩,白燕青,等.游离脂肪酸致胰岛素抵抗的相关分子机制研究进展[J].解放军医药杂志,2017,29(1):114-116. |